Mauritius - Re-Export of Vaccines for Human Use
Since 2014, Mauritius Re-Export of Vaccines for Human Use was up 47.3% year on year. At $32,503.62 in 2019, the country was ranked number 14 among other countries in Re-Export of Vaccines for Human Use. Mauritius is overtaken by Armenia, which was number 13 with $61,728 and is followed by Oman with $24,790.64. United States topped the ranking with $21,386,560.62 in 2019, that is a fall of 18% versus 2018. United Arab Emirates, Canada and Saudi Arabia respectively ranked number 2, 3 and 4 in this ranking. Guyana recorded the best 5 years average growth at +106.5% per year, while Trinidad and Tobago recorded the worst performance at -49.8% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2019 | 32,503.62 |
| 2018 | 31,086.41 |
| 2017 | 29,640.28 |
| 2016 | 34,382.24 |
| 2015 | 14,705.00 |
Download all data from 2005 to 2019
How does Mauritius rank in Re-Export of Vaccines for Human Use?
| # | 22 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
21,386,560.62 | 2019 | -18.0 % | -6.8 % | View data | |
| 2 |
#2
United Arab Emirates
|
7,990,507.15 | 2019 | +36.5 % | +27.7 % | View data | |
| 13 |
#13
Armenia
|
61,728.00 | 2016 | NA | NA | View data | |
| 14 |
#14
Mauritius
|
32,503.62 | 2019 | +4.6 % | +47.3 % | View data | |
| 15 |
#15
Oman
|
24,790.63 | 2016 | NA | -25.0 % | View data | |